Drug Trial Radar · NCT00355303
Comparison of Misoprostol and Prostaglandin E2 (PGE2) Gel for Induction of Labour in Premature Rupture of Membranes at Term
Last checked: Nov 20, 2026Latest source record: Jul 22, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
932
Actual
Start
Aug 2006
Primary completion
May 2013
Study completion May 2013
Sponsor
- Lead sponsor
- Nilratan Sircar Medical CollegeGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Jul 21, 2006
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether induction of labor with vaginal misoprostol application will result in fewer cesarean deliveries than vaginal PGE2 gel application in women with premature rupture of membranes at term.
Conditions
- Premature Rupture of Membranes at Term
Interventions
MisoprostolDrug
Vaginal application of Misoprostol tablets at 4 hrly interval with maximumof five doses
PGE2 gelDrug
PGE2 gel will be applied in poaterior fornix at six hrly interval with maximum of 2 doses
Primary outcomes
What the sponsor says the trial is designed to measure.
- Caesarean Section rateTime frame: 48 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nilratan Sircar Medical College, 138,AJC Bose Road,
Kolkata, West Bengal, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.